Treatment options for patients with myelodysplasia include supportive care, drug therapy and chemotherapy with stem cell transplant. Supportive care helps lessen the problems caused by myelodysplasia and may include transfusion therapy, the introduction of erythropoiesis-stimulating agents or antibiotic therapy, explains the National Institutes of Health.
Drug therapy may include immunosuppressive therapy or the medication lenalidomide, both of which reduce the need for red blood cell transfusions. Chemotherapy is used to treat myelodysplasia patients who develop acute leukemia, advises the NIH.
Stem cell transplants replace blood forming cells destroyed by other forms of treatment, states the NIH. Donor stem cells are frozen for storage and given to the patient through an infusion after completion of chemotherapy. The stem cells then grow into and restore the blood cells.